Characteristics | Number of Patients (%) |
---|---|
Sex | |
Male | 38 |
Female | 9 |
Treatment method | |
Distal Gastrectomy | 4 |
ESD + DG | 8 |
ESD | 35 |
Tumor location | |
Upper body | 6 |
Middle body | 11 |
Lower body | 39 |
Tumor size (mm) | |
< 10 mm | 14 |
< 20 mm | 25 |
< 30 mm | 7 |
≥ 31 mm | 1 |
Histologic type | |
Differentiated | 46 |
Undifferentiated | 1 |
Ulcer | |
Absence | 43 |
Presence | 4 |
Lympho-vascular invasion | |
Absence | 47 |
Presence | 0 |
Tumor invasion | |
Mucosa | 40 |
submucosa | 7 |
Size of lymph node | |
≤ 5 mm | 11 |
6 mm ≤ lymph node < 10 mm | 19 |
≥ 10 mm | 17 |
Number of lymph node | |
Single | 26 |
Multiple | 21 |
Shape of lymph node | |
Round | 20 |
Oval | 27 |
Location of lymph node | |
Peri-gastric | 37 |
Gastro hepatic | 7 |
Hepatoduodenal ligament | 1 |
Peri-pancreatic | 1 |
Peri-aortic | 4 |
Cardiophrenic | 1 |
Porta hepatitis | 1 |
Duration of follow up (35 patients treated with ESD) | |
< 4 year | 12 |
< 5 year | 15 |
< 6 years | 3 |
≥ 6 years | 5 |